04/15/2024
5:02 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
5:51 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
7:03 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/21/2024
8:20 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
5:33 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/14/2024
6:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024
4:00 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 424B5 | |
02/06/2024
4:05 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2024
11:15 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form EFFECT | |
01/12/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024
5:09 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
3:45 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/20/2023
3:30 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
10:40 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/03/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/27/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/19/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/05/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
5:27 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/10/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/07/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
He Is Giving Away Bitcoin (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
06/16/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/07/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2023
5:00 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2023
5:01 AM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2023
3:01 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 424B5 | |
04/26/2023
3:02 PM | Innate Pharma (Filer)
Innate Pharma SA (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
